Abstract
We report the first case of drug rash with eosinophilia and systemic symptoms (DRESS) following strontium ranelate (SR) treatment associated with systemic human HHV-7 reactivation. DRESS syndrome is a severe adverse drug-induced reaction presenting as a diffuse maculopapular skin rash with fever, hematological abnormalities (leukocytosis, eosinophilia, and/or atypical lymphocytosis), and multiorgan involvement. In our patient, diagnosis of DRESS was confirmed by the presence of six of the seven diagnostic criteria established in 2006 by the Japanese Research Committee on Severe Cutaneous Adverse Drug Reaction: maculopapular skin rash developing at least 3 weeks after starting therapy with a limited number of drugs, prolonged clinical symptoms after discontinuation of the causative drug, lymphadenopathy, fever, leukocyte abnormalities, and liver abnormalities. The diagnostic criteria of human herpesvirus (HHV)-6 reactivation have not been fulfilled in our patient, but a HHV-7 active infection was demonstrated by the presence of HHV-7 DNA and IgM in the patient’s serum. In fact, in some DRESS instances, reactivation of HHVs other than HHV-6 may be detected, including HHV-7, Epstein-Barr virus (EBV), and cytomegalovirus (CMV). Our case underlines that not only HHV-6 but also HHV-7 systemic reactivation may be associated with a more severe and even fatal course of this syndrome.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Cacoub P, Musette P, Descamps V, Meyer O, Speirs C, Finzi L et al (2011) The DRESS syndrome: a literature review. Am J Med 124:588–597
Husain Z, Reddy BY, Schwartz RA (2013) DRESS syndrome: part I. Clinical perspectives. J Am Acad Dermatol 68:693
Jeung YJ, Lee JY, Oh MJ, Choi DC, Lee BJ (2010) Comparison of the causes and clinical features of drug rash with eosinophilia and systemic symptoms and Stevens-Johnson syndrome. Allergy Asthma Immunol Res 2:123–126
Ben m’rad M, Leclerc-Mercier S, Blanche P, Franck N, Rozenberg F, Fulla Y, Guesmi M, Rollot F, Dehoux M, Guillevin L, Moachon L (2009) Drug-induced hypersensitivity syndrome: clinical and biologic disease patterns in 24 patients. Medicine (Baltimore) 88:131–140
Pompeu YA, Stewart JD, Mallal S, Phillips E, Peters B, Ostrov DA (2012) The structural basis of HLA-associated drug hypersensitivity syndromes. Immunol Rev 250:158–166
Hirahara K, Kano Y, Mitsuyama Y, Takahashi R, Kimishima M, Shiohara T (2010) Differences in immunological alterations and underlying viral infections in two well-defined severe drug eruptions. Clin Exp Dermatol 35:863–868
Sugita K, Tohyama M, Watanabe H, Otsuka A, Nakajima S, Iijima M, Hashimoto K, Tokura Y, Miyachi Y, Kabashima K (2010) Fluctuation of blood and skin plasmacytoid dendritic cells in drug-induced hypersensitivity syndrome. J Allergy Clin Immunol 126:408–410
Picard D, Janela B, Descamps V, D’Incan M, Courville P, Jacquot S, Rogez S, Mardivirin L, Moins-Teisserenc H, Toubert A, Benichou J, Joly P, Musette P (2010) Drug reaction with eosinophilia and systemic symptoms (DRESS): a multiorgan antiviral T cell response. Sci Transl Med 2:46ra62
Broccolo F, Drago F, Careddu AM, Foglieni C, Turbino L, Cocuzza CE, Gelmetti C, Lusso P, Rebora AE, Malnati MS (2005) Additional evidence that pityriasis rosea is associated with reactivation of human herpesvirus-6 and -7. J Invest Dermatol 124:1234–1240
Meunier PJ, Roux C, Seeman E, Ortolani S, Badurski JE, Spector TD, Cannata J, Balogh A, Lemmel EM, Pors-Nielsen S, Rizzoli R, Genant HK, Reginster JY (2004) The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis. N Engl J Med 350:459–468
EMA (2013) Reccommendation to restrict the use of Protelos/Osseor (strontium ranelate). http://www.ema.europa.eu/docs/en_GB/document_library/Press_release/2013/04/WC500142507.pdf Accessed 15 June 2013
Reginster JY, Brandi ML, Cannata-Andía J, Cooper C, Cortet B, Feron JM, Genant H, Palacios S, Ringe JD, Rizzoli R (2015) The position of strontium ranelate in today’s management of osteoporosis. Osteoporos Int 26:1667–1671
Cacoub P, Descamps V, Meyer O, Speirs C, Belissa-Mathiot P, Musette P (2013) Drug rash with eosinophilia and systemic symptoms (DRESS) in patients receiving strontium ranelate. Osteoporos Int 24:1751–1757
Iyer D, Buggy Y, O’Reilly K, Searle M (2009) Strontium ranelate as a cause of acute renal failure and dress syndrome. Nephrology (Carlton) 14:624. doi:10.1111/j.1440-1797.2009.01125.x
Bourgeois GP, Cafardi JA, Groysman V, Hughey LC (2012) A review of DRESS-associated myocarditis. J Am Acad Dermatol 66:e229–e236. doi:10.1016/j.jaad.2010.11.057
Sabatine MS, Poh KK, Mega JL, Shepard JA, Stone JR, Frosch MP (2007) Case records of the Massachusetts General Hospital. Case 36–2007. A 31-year-old woman with rash, fever, and hypotension. N Engl J Med 357:2167–2178
Ben m’rad M, Leclerc-Mercier S, Blanche P, Franck N, Rozenberg F, Fulla Y, Guesmi M, Rollot F, Dehoux M, Guillevin L, Moachon L (2009) Drug-induced hypersensitivity syndrome: clinical and biologic disease patterns in 24 patients. Medicine (Baltimore) 88:131–140. doi:10.1097/MD.0b013e3181a4d1a1
Schrijvers R, Gilissen L, Chiriac AM, Demoly P (2015) Pathogenesis and diagnosis of delayed-type drug hypersensitivity reactions, from bedside to bench and back. Clin Transl Allergy 5:31. doi:10.1186/s13601-015-0073-8
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Financial support
None
Conflicts of interest
None.
Rights and permissions
About this article
Cite this article
Drago, F., Cogorno, L., Broccolo, F. et al. A fatal case of DRESS induced by strontium ranelate associated with HHV-7 reactivation. Osteoporos Int 27, 1261–1264 (2016). https://doi.org/10.1007/s00198-015-3384-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00198-015-3384-7